1. Liu Yuhong#, Gao Jingtao, Du Jian, Shu Wei, Wang Lu, Wang Yufeng, Xue Zhongtan, Li Liang*, Xu Shaofa*, Pang Yu*.Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis.INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.2021.102.392-396.SCI |
2. Gao M#, Gao J#, Xie L#, Wu G.#, Chen W.#, Chen Y.#, Pei Y.#, Li G.#, Liu Y.#, Shu W., Fan L., Wu Q., Du J., Chen X., Tang P., Xiong Y., Li M., Cai Q., Jin L., Mei Z., Pang, Y.*, Li Liang*.Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study.CLINICAL MICROBIOLOGY AND INFECTION.2021.27(4).597-602.SCI |
3. Shi Li#, Gao Jingtao#, Gao Mengqiu#, Deng Ping, Chen Shu, He Minfu, Feng Wenjun, Yang Xiaoyun, Huang Yunhui, He Fang, Hu Yumeng, Lei Liping, Li Xuelian, Du Juan, Hu Xiaomeng, Liu Zhi, Tang Peijun, Han Junfeng, Wang Hua, Han Yi, Shu Wei, Sun Yuxian, Pei Yi*, Liu Yuhong*.Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.INFECTIOUS DISEASES AND THERAPY.2021.10(1).457-470.SCI |
4. 高静韬#,刘宇红*.以标准和循证支持精准抗击结核——世界卫生组织2021年结核病新规新政解读.国际流行病学传染病学杂志.2021.48(6).419-424.核心期刊 |
5. Du Jian#l, Zhang Lijie#, Liu Yuhong#, Shu Wei, Ma Yan, Gao, Jingtao, Li Liang*.Determination of the optimal time for N95 respirator for aerosol infection control.MEDICINE.2020.99(50).1-8.SCI |
6. Liu Yuhong#, Chen Shu, Gao Jingtao, Zhang Yao, Booher Kimberly, Ding Xiaofen, Shu Wei, Du Jian, Bao Jing, Hafner Richard, Hamilton Carol D.,Li Liang*.The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building..Infectious Diseases of Poverty.2020.9(52).1-7.SCI |
7. Shu Wei#, Du Jian#, Liu Yuhong#, Wang Yufeng, Huo Fengmin, Jiang Guanglu, Li Liang*, Pang Yu*.External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES.2020.39(5).871-875.SCI |
8. 谢莉#,高静韬#,马丽萍,张立群,孔忠顺,吴晓光,刘荣梅,陈红梅,宋艳华,李雪莲,黄麦玲,李强,吕子征,刘宇红*,高孟秋,.含贝达喹啉方案治疗耐多药肺结核对患者心电图QT间期的影响.中国防痨杂志.2020.42(7).687-694.核心期刊 |
9. Du Jian#, Shu Wei#, Liu Yuhong#, Wang Yufeng, Zhan Ying, Yu Kexin, Gao Jingtao, Li Liang*, Pang Yu*.Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES.2020.39(2).339-343.SCI |
10. 李亮#,唐神结,杜建,刘宇红*.建国70年我国结核病化学治疗的回顾与展望.中华结核和呼吸杂志.2019.42(10).723-726.核心期刊 |
11. Liu, Yuhong#, Pang Yu, Du Jian, Shu Wei, Ma Yan, Gao Jingtao, Zhang Lijie, Xu Shaofa*, Li Liang*.An Overview of Tuberculosis-Designated Hospitals in China, 2009-2015: A Longitudinal Analysis of National Survey Data.BIOMED RESEARCH INTERNATIONAL.2019.2019.1-8.SCI |
12. 刘宇红#* .注射类抗结核药物在我国耐药结核病治疗中的作用.中华结核和呼吸杂志.2019.42(6).401-404.核心期刊 |
13. Du Jian#, Shu Wei#, Liu Yuhong#, Wang Yufeng, Zhan Ying, Yu Kexin, Gao Jingtao, Li Liang*, Pang Yu*.Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES.2019.38(10).1961-1968.SCI |
14. 刘宇红#, 高微微*, 李亮,杜建,马艳,舒薇,吕晓亚,谢仕恒,王红红,陈婷.单耐药和多耐药复治菌阳肺结核个体化治疗效果探讨.中华结核和呼吸杂志.2018.41(1).25-31.核心期刊 |